Wei Ma

1.6k total citations
80 papers, 1.2k citations indexed

About

Wei Ma is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wei Ma has authored 80 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Surgery and 19 papers in Cancer Research. Recurrent topics in Wei Ma's work include MicroRNA in disease regulation (13 papers), Spinal Dysraphism and Malformations (10 papers) and Cancer-related molecular mechanisms research (8 papers). Wei Ma is often cited by papers focused on MicroRNA in disease regulation (13 papers), Spinal Dysraphism and Malformations (10 papers) and Cancer-related molecular mechanisms research (8 papers). Wei Ma collaborates with scholars based in China, United States and Hong Kong. Wei Ma's co-authors include Zhengwei Yuan, Xiaowei Wei, Hui Gu, Dan Liu, Kai‐Jin Wang, Guoqing Yan, Ning Li, Yong‐Xian Cheng, Wenting Luo and Weilin Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Wei Ma

79 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Ma China 20 585 280 164 102 96 80 1.2k
Amir Fattahi Iran 23 547 0.9× 210 0.8× 129 0.8× 102 1.0× 353 3.7× 93 1.7k
Mohammad Alanazi Saudi Arabia 16 757 1.3× 322 1.1× 112 0.7× 59 0.6× 52 0.5× 76 1.4k
Lingling Jiang China 23 940 1.6× 345 1.2× 96 0.6× 80 0.8× 65 0.7× 67 1.7k
Jian Liao China 16 428 0.7× 185 0.7× 142 0.9× 97 1.0× 44 0.5× 58 1.3k
Kwang Il Nam South Korea 25 1.1k 1.8× 262 0.9× 270 1.6× 91 0.9× 78 0.8× 59 2.0k
Shu Li China 24 914 1.6× 254 0.9× 177 1.1× 147 1.4× 27 0.3× 86 1.8k
Li Wu China 19 782 1.3× 285 1.0× 207 1.3× 78 0.8× 44 0.5× 57 1.6k
Kakali Sarkar United States 16 426 0.7× 254 0.9× 118 0.7× 60 0.6× 47 0.5× 22 1000
Seyed Mehdi Kalantar Iran 18 393 0.7× 163 0.6× 90 0.5× 59 0.6× 200 2.1× 103 1.1k

Countries citing papers authored by Wei Ma

Since Specialization
Citations

This map shows the geographic impact of Wei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ma more than expected).

Fields of papers citing papers by Wei Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ma. The network helps show where Wei Ma may publish in the future.

Co-authorship network of co-authors of Wei Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ma. A scholar is included among the top collaborators of Wei Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ma. Wei Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jia, Shanshan, Weidong Xie, Chunqing Yang, et al.. (2025). Combining lipidomics and machine learning to identify lipid biomarkers for nonsyndromic cleft lip with palate. JCI Insight. 10(9). 2 indexed citations
3.
Tian, Zhiwei, et al.. (2024). Fruits hidden by green: an improved YOLOV8n for detection of young citrus in lush citrus trees. Frontiers in Plant Science. 15. 1375118–1375118. 12 indexed citations
5.
Zhang, Xiulian, Xueliang Li, Wei Ma, et al.. (2023). Astragaloside IV restores Th17/Treg balance via inhibiting CXCR4 to improve chronic obstructive pulmonary disease. Immunopharmacology and Immunotoxicology. 45(6). 682–691. 8 indexed citations
6.
Ma, Wei, Shuxin Xuan, Dandan Li, et al.. (2023). Hormones and carbohydrates synergistically regulate the formation of swollen roots in a Chinese cabbage translocation line. Horticulture Research. 10(8). 8 indexed citations
7.
Sun, Xue, Wenting Luo, Hui Gu, et al.. (2023). Small but strong: the emerging role of small nucleolar RNA in cardiovascular diseases. Frontiers in Cell and Developmental Biology. 11. 1292925–1292925. 10 indexed citations
8.
Wei, Xiaowei, Wei Ma, Yusi Liu, et al.. (2022). Neural Stem Cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem Cells in Therapy of Spinal Bifida Aperta. Stem Cells Translational Medicine. 11(5). 539–551. 11 indexed citations
9.
Liu, Yusi, Xiaowei Wei, Dan Liu, et al.. (2021). Nuclear factor I-C disrupts cellular homeostasis between autophagy and apoptosis via miR-200b-Ambra1 in neural tube defects. Cell Death and Disease. 13(1). 17–17. 21 indexed citations
10.
Tang, Jia, Meihua Tan, Yihui Deng, et al.. (2021). Two Novel Pathogenic Variants of TJP2 Gene and the Underlying Molecular Mechanisms in Progressive Familial Intrahepatic Cholestasis Type 4 Patients. Frontiers in Cell and Developmental Biology. 9. 661599–661599. 8 indexed citations
12.
Tang, Jia, Li Q, Hui Li, et al.. (2020). Prenatal diagnosis of skeletal dysplasias using whole exome sequencing in China. Clinica Chimica Acta. 507. 187–193. 18 indexed citations
13.
Jia, Shanshan, Xiaowei Wei, Yanfu Wang, et al.. (2019). Maternal, paternal, and neonatal risk factors for neural tube defects: A systematic review and meta‐analysis. International Journal of Developmental Neuroscience. 78(1). 227–235. 16 indexed citations
14.
Tang, Jia, Wei Ma, Runze Jiang, et al.. (2019). Novel SPEG variant cause centronuclear myopathy in China. Journal of Clinical Laboratory Analysis. 34(2). e23054–e23054. 12 indexed citations
15.
Yuan, Zhengwei, et al.. (2019). Spatiotemporal expression of leukemia inhibitory factor receptor protein during neural tube development in embryos with neural tube defects. Neural Regeneration Research. 15(4). 705–705. 4 indexed citations
16.
Yuan, Zhengwei, Xiaowei Wei, Hui Li, et al.. (2016). Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta. Journal of Materials Science Materials in Medicine. 27(4). 77–77. 39 indexed citations
17.
Di, Lei, Guoqing Yan, Ling‐Yu Wang, et al.. (2013). Two new neolignans from Patrinia scabra with potent cytotoxic activity against HeLa and MNK-45 cells. Archives of Pharmacal Research. 36(10). 1198–1203. 13 indexed citations
18.
Li, Yumei, et al.. (2012). Effects of irradiation on osteoblast‐like cells on different titanium surfacesin vitro. Journal of Biomedical Materials Research Part B Applied Biomaterials. 101B(1). 9–17. 8 indexed citations
19.
Wang, Jianbo, Qingwei Wang, Hong Liu, et al.. (2012). The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 27(6). 779–788. 73 indexed citations
20.
Zhang, Hong‐Xing, Wen Su, Guofu Huang, et al.. (2008). Depletion of c-Myc Inhibits Human Colon Cancer Colo 320 Cells' Growth. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 229–237. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026